18 Sep 2008 | 12:25
Lupin acquires majority stake in Pharma Dynamics, South Africa
Lupin has completed the acquisition of a majority stake in Pharma
Dynamics (PD) in South Africa. PD is amongst the fastest growing
generic companies and commando a premium image with the medical
profession with a clear leadership in the cardiovascular segment.
Lupin acquires majority stake in Pharma Dynamics, South Africa
Lupin has completed the acquisition of a majority stake in Pharma
Dynamics (PD) in South Africa. PD is amongst the fastest growing
generic companies and commando a premium image with the medical
profession with a clear leadership in the cardiovascular segment.
PD
reported revenues of Rand 118 miilion for the year ending February
2008. PD ranks at number 6 amongst generic companies and is currently
growing at 34% per annum as per IMS. The founder, Paul Anley, remains
with a significant equity holding and will continue as the CEO of the
organization. The South African market is estimated at US$ 2.5 billion.
Generics currently are a third of the market and growing rapidly.
The company made this announcement during the trading hours today, 18 September 2008.
0 comments:
Post a Comment